Physician profile
Alan Jarrett
NPI 1184616922
$826.60
in general payments reported to CMS, 2019-2025
13 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.86 · 2020: $18.30 · 2021: $57.54 · 2022: $241 · 2023: $71.77 · 2024: $189 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.24 | 2022-2025 | |
| Oyster Point Pharma, INC. | $125.99 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $108.53 | 2022-2025 | Rocklatan, Precision 1 |
| Astellas Pharma US INC | $79.00 | 2024 | Izervay |
| Allergan, INC. | $42.58 | 2020-2022 | |
| Akorn Operating Company LLC | $33.95 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $28.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.39 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.86 | 2019 | |
| Aerie Pharmaceuticals, INC. | $23.59 | 2021 | |
| Thea Pharma INC. | $20.30 | 2023 | |
| Bausch & Lomb Americas INC. | $15.54 | 2022 | |
| Kala Pharmaceuticals, INC. | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.